Four Thought Financial Partners, LLC Edwards Lifesciences Corp Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $21,616 - $28,476	-298 Reduced 9.54%	2,827 $270 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $9,379 - $11,819	-152 Reduced 4.64%	3,125 $238 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $18,636 - $25,119	-269 Reduced 7.59%	3,277 $227 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $14,002 - $16,224	-172 Reduced 4.63%	3,546 $334 Million
Q1 2023 May 04, 2023	SELL	$74.26 - $84.51 $4,678 - $5,324	-63 Reduced 1.67%	3,718 $308 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $258,242 - $330,610	3,781 New	3,781 $282 Million

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.